Research priorities include fully characterizing GLP-3s mechanisms and receptor interactions, establishing optimal dosing and administration protocols, conducting larger-scale clinical trials for various metabolic conditions, exploring combination approaches with GLP-1 and other interventions, and identifying patient populations most likely to benefit
The FDA issued more than 50 warning letters to GLP-1 vendors in September 2025, with several explicitly naming retatrutide
Common praise: - Lower cost than branded Wegovy or Zepbound - Quick, convenient online signup - Doorstep delivery with supplies included - Real weight-loss results when dosed correctly Common complaints: - Billing surprises after promotional pricing ends - Difficulty canceling the subscription - Shipping delays, especially for cold-chain products - Inconsistent provider communication - Uncertainty about the dispensing pharmacy The cancellation-friction complaint is nearly universal in this industry
Compound Pricing BrandName Semaglutide: Brand name drugs like Ozempic and Wegovy retail between $800 and $1,200 monthly due to manufacturing, marketing, and patent protections
Everyone who takes GLP-1 shots is different, and so is their reaction to or suitability for these medications
